The biotechnology company's development program for drug candidate rusfertide was put on hold by the Food and Drug Administration.
News
- Protagonist, Schlumberger fall; Invesco, Thermo Fisher rise - mySA
- One year and 1 million tests later, Community Labs plans to triple lab capacity - San Antonio Report
Community Labs leaders announced the milestone Friday on its one-year anniversary and, in partnership with biotech nonprofit BioBridge Global, ...
- San Antonio-based bioAffinity Technologies' first cancer test ready to hit the market
More than seven years after its launch, bioAffinity Technologies is on the cusp of commercializing its initial product, the CyPath Lung cancer ...
- How social media is playing a part in vaccine hesitancy and misinformation | WOAI
... of the Lone Star State, Dr. Jeff Dennis with TTUHSC Graduate School of Biomedical Sciences said many Texans don't like being told what to do.
- Precision Medicine Software Market Worth $2.55 Billion by 2028 - Yahoo Finance
... Research, Academia, Pharma, Biotech) - Forecast to 2028 ... For instance, in July 2020, the San Antonio Partnership for Precision Therapeutics ...